| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | A synthesized peptide derived from human HN1 was used as the immunogen for the HN1 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
HN1 Antibody / JPT1 / Hematological and neurological expressed 1 is a anti-HN1 Rabbit antibody Recombinant Rabbit Monoclonal clone 31J27 supplied in Liquid format. Recommended for workflows such as Flow cytometry (FACS), Immunofluorescence (IF), Immunocytochemistry (ICC), Western blot (WB) with listed reactivity in Human, Mouse, Rat.
Key elements and design rationale
- Target: HN1
- Antibody details: Rabbit, Recombinant Rabbit Monoclonal, clone 31J27, isotype Rabbit IgG
- Format: Liquid
- Applications (as listed): FACS, IF, ICC, WB
Biological background
Studies have shown that Hematological and neurological expressed 1 participates in proliferation and survival pathways, potentially through interaction with kinases and growth factor receptors. Detection with HN1 antibody has revealed changes in expression during cell cycle progression and differentiation, supporting the idea that this protein integrates extracellular signals with cellular responses. In hematopoietic cells, HN1 may regulate developmental transitions, while in the nervous system, it is linked to neuronal outgrowth and plasticity. Its broad expression pattern suggests that HN1 contributes to multiple cellular functions beyond its namesake tissues.
In cancer research, HN1 has drawn attention as a marker of poor prognosis in several malignancies. Elevated levels have been reported in breast, lung, and liver cancers, where it correlates with increased proliferation and invasiveness. Research using HN1 antibody has demonstrated that silencing or overexpression of HN1 alters tumor cell behavior, implicating it in oncogenic pathways. Because of its association with tumor growth and survival, Hematological and neurological expressed 1 is being investigated as a potential biomarker and therapeutic target.
HN1 antibody is widely used in western blotting, immunohistochemistry, and immunofluorescence. Western blotting identifies expression changes under experimental conditions such as growth factor stimulation. Immunohistochemistry demonstrates tissue and tumor specific localization, while immunofluorescence reveals cytoplasmic and nuclear distribution. These applications make HN1 antibody versatile for investigating fundamental biology and translational cancer research.
By supplying validated HN1 antibody reagents,
Research relevance and current trends
- Connecting protein-level changes to phenotype using orthogonal readouts (genetic perturbation, transcriptomics, imaging).
- Considering isoforms and post-translational regulation when interpreting protein-level changes.
- Comparing results across species and model systems with matched controls.
Common research applications
- Western blotting: compare relative abundance and activation-state changes across conditions.
- Immunofluorescence: visualize subcellular distribution and cell-to-cell heterogeneity.
- Flow cytometry: quantify target-positive populations and signal shifts at single-cell resolution.
Interpret changes in signal alongside appropriate controls and, when relevant, in parallel with total-protein or pathway readouts.
Notes for experimental interpretation
- Signal can reflect expression level, isoform composition, and post-translational state; interpret results in the context of your model system and stimuli.
- Species differences and sample matrices can influence epitope recognition; prioritize matched controls and orthogonal confirmation when feasible.
Antibody notes: Monoclonal antibodies provide a defined epitope recognition profile that can support consistent comparisons across experiments.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
